Search

Displaying results 5661 - 5670 of 6079 in total
  1. Drug

    EP-1043

    go.drugbank.com/drugs/DB06118
    Experimental

    EP-1043 is an epitope-based recombinant protein vaccine designed to induce HIV-1 specific helper T-lymphocyte (HTL) responses. The vaccine consists of a string of 18 HIV-derived major histocompatibility complex (MHC) Class II restricted ...

  2. Drug

    4-O-Demethylpenclomedine

    go.drugbank.com/drugs/DB06331
    Experimental

  3. Drug

    XR5944

    go.drugbank.com/drugs/DB06364
    Experimental

    XR5944 is a DNA bis-intercalating anticancer drug. It has both intercalating and antineoplastic activities.

  4. Drug

    Evernimicin

    go.drugbank.com/drugs/DB06431
    Experimental

  5. Drug

    Tecastemizole

    go.drugbank.com/drugs/DB06457
    Experimental

  6. Drug

    Liatermin

    go.drugbank.com/drugs/DB06489
    Investigational

  7. Drug

    L523S

    go.drugbank.com/drugs/DB06498
    Investigational

    According to Nemunaitis J., et al, "L523S is an immunogenic lung cancer antigen that has demonstrated preclinical safety when the gene is injected intramuscularly as an expressive plasmid (pVAX/L523S) and when delivered following incorpo...

  8. Drug

    Siramesine

    go.drugbank.com/drugs/DB06555
    Experimental

  9. Drug

    alpha-Hydroxy glycineamide

    go.drugbank.com/drugs/DB06568
    Experimental

    Alpha-hydroxy glycineamide (αHGA) is the active antiviral metabolite of tri-peptide glycyl-prolyl-glycine-amide (GPG-NH2). αHGA inhibits the replication of HIV-1 in vitro by interfering with the capsid formation. It also has an effect on...

  10. Drug

    Baminercept

    go.drugbank.com/drugs/DB06576
    Investigational